Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Labs & Scientific Resources
>
Resources for Researchers
>
DMID Resources for Researchers
>
Phase I Clinical Trial Units for Therapeutics
Resources for Researchers
DMID Resources for Researchers
Phase I Clinical Trial Units for Therapeutics
Eligibility Criteria
Assurances to Users
Application Process
Approval Process
User Requirements
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Order publications
Skip Stay Connected
Stay Connected
Contact Info
Mary Smith
Project Manager
mary.smith@nih.gov
Additional Information From NIAID
All microbiology and infectious diseases resources (non HIV/AIDS)
All NIAID resources
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Resources for Researchers
Skip Content Marketing
Share this:
Phase I Clinical Trial Units for Therapeutics
Assurances to Users
DMID will provide clinical research sites qualified by training and experience, safety oversight, clinical monitoring, data management and regulatory management.
All information provided will be treated as confidential. Users may enter into a Materials Transfer Agreement and/or Clinical Trial Agreement as appropriate.
All PIs and collaborators will retain publication rights.
Last Updated November 13, 2012